ロード中...
Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis
BACKGROUND: Recent clinical studies have shown that initial therapy with combined BRAF and mitogen-activated extracellular signal-regulated kinase (MEK) inhibition is more effective in metastatic melanoma than single-agent BRAF inhibitors. However, the response rates with single-agent BRAF are low....
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692200/ https://ncbi.nlm.nih.gov/pubmed/29180872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S147438 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|